You searched for "retinopathy of prematurity"
Retinopathy of prematurity
1 April 2014
| Nana Theodorou
|
EYE - Vitreo-Retinal
This review article describes the pathophysiology of retinopathy of prematurity (ROP). The authors start by introducing the condition and its incidence. There is extensive information on the pathophysiology mechanisms involved in the condition to include normal and pathological retinal development....
The screening and treatment of retinopathy of prematurity
1 December 2013
| B Manoj, F Dean
|
EYE - Paediatrics, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
A male child is born at 31 weeks and requires 100% oxygen supplementation with intensive care. What would be the ophthalmic management of this child? In the first instance, it will be useful to know the screening criteria and protocol....
Telemedicine retinopathy of prematurity (ROP) screening
5 June 2020
| Ivan Yip
|
EYE - Vitreo-Retinal
The Auckland Regional Telemedicine ROP network utilises wide-field digital imaging for ROP screening. Results are from 2006-2015; 1181 infants were screened over three neonatal intensive care units; 83 infants with ROP were identified. Screening rates increased over the 10 years...
Outcomes of reinjection of Ranibizumab for reactivation of retinopathy of prematurity
The authors present their data from Egypt assessing the effects of Ranibizumab reinjection for neonates with retinopathy of prematurity (ROP). Doses given were 0.25mg/0.025mL. They screened 2318 infants with 115 (5%) of infants with a mean post menstrual age (PMA)...Retinopathy of prematurity treatment in the South West of England: long-term outcomes 1997-2008
1 December 2014
| Anna Pang, Jonathan Park, Anthony Quinn, Roland Ling
|
EYE - Vitreo-Retinal
Retinopathy of prematurity (ROP) is a condition that affects the developing retinal vascular system of pre-term babies. If left untreated, ROP can lead to severe visual impairment. The severe visual impairment caused by untreated ROP can be prevented by screening...
Assessing failure of laser coagulation treatment for type 1 retinopathy of prematurity
7 April 2021
| Kareem Waleed Alsaffarini
|
EYE - Vitreo-Retinal
The authors present the findings of a retrospective study to examine the cause of treatment failures in type 1 retinopathy of prematurity (ROP). They reviewed the medical charts of all infants with persistent disease post laser treatment at Uppsala University...
Combined versus traditional photocoagulation treatment for aggressive posterior retinopathy of prematurity (APROP)
The purpose was to report the outcomes of the combined treatment of sparing laser photocoagulation and intravitreal Bevacizumab (IVB) treatment versus conventional laser photocoagulation intervention in APROP. This was a study of 18 eyes of nine infants. One was excluded...
DIGIROP efficacy for detecting treatment-requiring retinopathy of prematurity (TR-ROP)
This article examines the efficacy of using the DIGIROP online prediction model in estimating the risk of retinopathy of prematurity (ROP) requiring treatment in two Portuguese hospitals. Portuguese screening criteria for ROP mirrors that of the UK (<32 weeks gestation...
